Jump to navigation
A new review article discusses pluripotent stem cell models employed in the understanding and treatment of hearing loss
Research using iPSC-derived organoids support primary cell‐intrinsic and secondary mechanical causes of altered development in the congenital diaphragmatic hernia lung
Selecting cells with high inherent reprogramming potential via CAG promoter activity represents a possible means to improve reprogramming efficiency
Synthetic mRNA‐induced differentiation may accelerate our understanding of Parkinson's disease development in GD1 patients
A new review summarizes advances in iPSC‐based modeling to explore glial cell involvement in neurodegenerative diseases
iPSC-derived AMD model used to investigate the interplay between lysosome function and complement activation in the hope of identifying therapeutic targets
The miR‐183/96/182 cluster controls retinal tissue morphogenesis and represents an important regulator of PAX6 expression
Modulating the miR‐184/Wnt3 pathway in embryonic stem cells may provide for the development of efficient cell therapies for the damaged heart
CDK8/19 Mediator components control pluripotent stem cell differentiation and self-renewal and regulate preimplantation naïve epiblast gene expression
Kanagaki et al. underscore the potential utility of iPSC-derived AT1cells in understanding their differentiation from AT2 cells in vitro.
The Stem Cells Portal provides coverage of the latest research, clinical applications, policies, and developments in the stem cell and regenerative medicine fields.
Clinical Trials: Stem Cells and Regenerative Medicine